Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy

Completed

Conditions studied: Barrett Esophagus

In brief

This study tests the impact of narrow band imaging (NBI) on endoscopists' accurate detection of visible lesions and dysplasia in patients with Barrett's esophagus, as well as the effect of NBI on the choice of primary treatment modality among endoscopists performing endoscopic eradication therapy (EET).

Key facts

Study ID

NCT03191604

Run by

Northwestern University

People needed

46

Starts

2017-11-01

Expected to finish

2019-05-10

Last updated by the study team

2019-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Endoscopists familiar with EET.

You may not qualify if…

• Endoscopists not familiar with EET or non-endoscopists.
• Special populations will not be included in this study.

Where it is running

• Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.